Some physicochemical aspects of L-asparaginase therapy.
D000818:Animals; D001215:Asparaginase / Q000032:analysis / Q000097:blood / Q000302:isolation & purification / Q000627:therapeutic use; D001769:Blood; D004355:Drug Stability; D004885:Erwinia / Q000201:enzymology; D004926:Escherichia coli / Q000201:enzymology*; D005260:Female; D005972:Glutaminase / Q000032:analysis; D006207:Half-Life; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007525:Isoelectric Focusing; D007700:Kinetics; D051379:Mice; D008815:Mice, Inbred Strains; D010455:Peptides; D013237:Stereoisomerism
D010455:Peptides; D001215:Asparaginase; D005972:Glutaminase